Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma

Oral Oncology

Volumn 33, Issue 5, 1997, Pages 369-374

  Moriyama, M ^a   Kumagai, S ^a   Kawashiri, S ^a   Kojima, K ^a   Kakihara, K ^a   Yamamoto, E ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Flt 1; Flt 4; KDR; Oral cancer; Vascular endothelial growth factor (VEGF); Vessel density

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VASCULAR ENDOTHELIUM;

EID: 0031423736     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00025-0     Document Type: Article

References (28)

1. Folkman, J., Tumor angiogenesis. Advances in Cancer Research, 1985, 43, 175-203.
2. Rak, J. W., Croix, B. D. and Kerbel, R. S., Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs, 1995, 6, 3-18.
3. Folkman, J., Clinical applications of research on angiogenesis. New England Journal of Medicine, 1996, 333, 1757-1763.
4. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A. et al., Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry, 1994, 269, 26988-26995.
5. Kaipainen, A., Korhonen, J., Mustonen, T. et al., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Science USA, 1995, 92, 3566-3570.
6. Joukov, V., Pajusola, K., Kaipainen, A. et al., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGF-3) and KDR (VEGF-2) receptor tyrosine kinases. EMBO Journal, 1996, 15, 290-298.
7. Vuckovic, M., Ponting, J., Terman, B. I. et al., Expression of the vascular endothelial growth factor receptor, KDR, in human placenta. Journal of Anatomy, 1996, 188, 361-366.
8. Hewett, P. W. and Murray, J. C., Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochemical and Biophysical Research Communications, 1996, 221, 697-702.
9. Toi, M., Hoshina, S., Takayanagi, T. et al., Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Japanese Journal of Cancer Research, 1994, 85, 1045-1049.
10. Takahashi, Y., Kitadai, Y., Corazon, D. B. et al., Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Research, 1995, 55, 3964-3968.
11. Samoto, K., Ikezaki, K., Ono, M. et al., Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Research, 1995, 55, 1189-1193.
12. Weidner, N., Carroll, P. R., Flax, J. et al., Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology, 1993, 143, 401-409.
13. Weidner, N., Semple, J. P., Welch, W. R. et al., Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine, 1991, 324, 1-8.
14. Penfold, C. N., Partridge, M., Rojas, R. et al., The role of angiogenesis in the spread of oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery, 1996, 34, 37-41.
15. Petruzzelli, G. J., Tumor angiogenesis. Head and Neck, 1996, 18, 283-291.
16. Williams, J. K., Carlson, G. W., Cohen, C., et al., Tumor angiogenesis as a prognostic factor in oral cavity tumors. American Journal of Surgery, 1994, 168, 373-380.
17. Shintani, S., Rafael, A., Yoshihama, Y. et al., Immunohistochemical detection of microvessels in oral squamous cell carcinomas. Japanese Journal of Oral Maxillofacial Surgery, 1994, 40, 645-650.
18. Gleich, L. L., Biddinger, P. W., Pavelic, Z. P. et al., Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head and Neck, 1996, 18, 343-346.
19. Leedy, D. A., Trune, D. R., Kronz, J. D. et al., Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngology Head and Neck Surgery, 1994, 111, 417-422.
20. Yamamoto, E., Miyakawa, A. and Kohama, G., Mode of invasion and lymph node metastatis in squamous cell carcinoma of the oral cavity. Head and Neck, 1984, 6, 938-947.
21. Miettinen, M., Lindenmayer, A. E. and Chaubal, A., Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Modem Pathology, 1994, 7, 82-90.
22. Ohsawa, M., Nara, N., Tomita, Y. et al., Use of immunohistochemical procedures in diagnosing angiosarcoma. Cancer, 1995, 75, 2867-2874.
23. Parums, D. V., Cordell, J. L., Micklem, K. et al., JC70A: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. Journal of Clinical Pathology, 1990, 43, 752-757.
24. Elizabeth, R. H., Russell, L., Nora, K., et al., Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 1992, 340, 1120-1124.
25. Shibuya, M., Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Advances in Cancer Research, 1995, 67, 281-316.
26. Lauria, R., Perrone, F., Carlomagno, C. et al., The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer, 1995, 76, 1772-1778.
27. Maehara, Y., Oshiro, T., Baba, H. et al., Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery, 1995, 117, 380-385.
28. Yoshizawa, M., Shingaki, S., Nakajima, T. et al., Histopathological study of lymphatic invasion in squamous cell carcinoma (O-1N) with high potential of lymph node metastasis. Clinical Experimental Metastatis, 1994, 12, 347-356.